Symptomatology and Neuropsychological Functioning in Cannabis Using Subjects at Ultra-High Risk for Developing Psychosis and Healthy Controls
- 1 March 2010
- journal article
- research article
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 44 (3) , 230-236
Abstract
Objective: The relationship between cannabis use and psychosis has been studied intensively. Few data, however, are available on the relationship between cannabis use, ultra-high risk for developing psychosis and neurocognition. The aim of the present cross-sectional study was therefore to investigate the relationship between cannabis use, ultra-high-risk (UHR) symptoms and cognitive functioning in UHR patients and healthy controls. Methods: A total of 63 ultra-high-risk patients (34 cannabis users) and 58 control subjects (28 cannabis users) were assessed with clinical measures and a neuropsychological test battery. Patients were eligible for the study if they were between the ages of 12 and 35 years and if they fell into one or more of the following inclusion groups: familial risk and reduced functioning, attenuated psychotic symptoms, brief limited intermittent psychotic symptoms and basic symptoms. Control subjects were eligible for the study if they were between the ages 12 and 35, had no present or past psychiatric illness, no family history of psychiatric illness, no drug use in the non-cannabis-using group, and use of at least four joints per week in the cannabis-using control group. Results: In the UHR and the control group, cannabis users experienced more basic symptoms and UHR symptoms than the non-cannabis users. Moreover, cannabis users in the control group performed at the level of the UHR subjects on a test of verbal memory and verbal fluency. Frequency of cannabis use correlated with severity of several UHR symptoms. Conclusions: Cannabis-using UHR patients have more basic symptoms than non-using patients. In addition, healthy cannabis users have more subclinical UHR and basic symptoms and more neuropsychological dysfunctions than non-cannabis users. More frequent cannabis use was related to increased severity of certain UHR symptoms.Keywords
This publication has 21 references indexed in Scilit:
- Cannabis use and risk of psychotic or affective mental health outcomes: a systematic reviewThe Lancet, 2007
- Neurocognitive indicators for a conversion to psychosis: Comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosisSchizophrenia Research, 2007
- Cannabis abuse and risk for psychosis in a prodromal samplePsychiatry Research, 2007
- Cannabis use and psychotic disorders: an updateDrug and Alcohol Review, 2004
- Early adolescent cannabis exposure and positive and negative dimensions of psychosisAddiction, 2004
- Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequencesSchizophrenia Research, 2004
- Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) groupSchizophrenia Research, 2003
- Cannabis Use is Not Associated With the Development of Psychosis in an ‘Ultra’ High-Risk GroupAustralian & New Zealand Journal of Psychiatry, 2002
- Prospective Diagnosis of the Initial Prodrome for Schizophrenia Based on the Structured Interview for Prodromal Syndromes: Preliminary Evidence of Interrater Reliability and Predictive ValidityAmerican Journal of Psychiatry, 2002
- Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studiesJournal of Psychiatric Research, 2001